Decoy Therapeutics Inc.
Decoy Therapeutics Inc. scores highest on Price (92) and lowest on Nitro (3). Its PosiPenta is 47.86 out of 100, around the middle of similar companies.
On the Penta Grid this week, Decoy Therapeutics Inc. is Grid #317 of 837 in the Healthcare sector in United States, and Grid #2,125 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Decoy Therapeutics Inc. | 47.86 | 92 | 50 | 3 | 46 | 48 |
| INVO Fertility, Inc. | 43.24 | 98 | 53 | 4 | 39 | 22 |
| Sunshine Biopharma, Inc. | 39.57 | 50 | 54 | 4 | 66 | 24 |
| Silo Pharma, Inc. | 41.29 | 46 | 45 | 14 | 60 | 42 |
| HCW Biologics Inc. | 29.10 | 47 | 41 | 8 | 21 | 29 |
| Calidi Biotherapeutics, Inc. | 25.19 | 40 | 40 | 5 | 16 | 25 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.09 |
| P/B ratio | 0.65 |
EEarnings
| Trailing EPS | ₹1206.67 |
| Forward EPS | ₹-784.24 |
NNitro
| Price | 110.82 |
| 52-week high | 4842.97 |
| 52-week low | 108.92 |
| Fall from 52-week high | 97.7% |
TTorque
| Return on equity (ROE) | -827.77% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.64 |
| Market cap | ₹26 Cr |
| Insider holding | 10.44% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Decoy Therapeutics Inc.'s PosiPenta score?
Decoy Therapeutics Inc.'s PosiPenta is 47.86 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Decoy Therapeutics Inc. stand on the Penta Grid?
On the Penta Grid this week, Decoy Therapeutics Inc. is Grid #317 of 837 in the Healthcare sector in United States, and Grid #2,125 of 4,000 in United States.
Which PosiPenta pillar is strongest for Decoy Therapeutics Inc.?
Price (valuation), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Decoy Therapeutics Inc.?
Nitro (momentum), with a score of 3 out of 100: much weaker than most similar companies.
Has Decoy Therapeutics Inc.'s PosiPenta changed since last week?
Yes, it rose 0.03 points, from 47.83 to 47.86.
PositoAI is for research and education only and is not investment advice.